Cardiomyopathy Trial, Recruiting NCT00733590 Sponsor: Johns Hopkins University Condition: Cardiomyopathy
Back to Cardiomyopathy

Cardiomyopathy Trial, Recruiting

NCT00733590
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had a heart attack at least 4 weeks ago
  • People who have had reduced heart pumping function (not caused by blocked arteries) for at least 9 months
  • People whose heart is pumping at 35% or less of its normal capacity
  • People who have had their ICD (implanted heart shock device) battery/generator replaced within the last 24 months, where the device was originally implanted to prevent a first serious heart rhythm event
  • People whose ICD was originally implanted as a preventive measure before experiencing a life-threatening heart rhythm problem

Who may not be able to join:

  • People whose ICD generator was replaced because they had already experienced a serious heart rhythm event (rather than as a preventive measure)
  • People who are unable or unwilling to give their formal agreement to participate in the study
  • People with the most severe level of heart failure, where symptoms occur even at rest (confirm with trial site)
  • People who already have a separate, pre-existing medical reason requiring a pacemaker

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Katherine C Wu, MD, Associate Professor of Medicine Johns Hopkins University

Phone: 410-502-7283

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 June 2003
Est. completion
1 March 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Arrhythmic Sudden Death defined as a therapy from the ICD for rapid VT or VF or a ventricular arrhythmia not corrected by the ICD

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov